CH₃CH₃
AI image · google/nano-banana-2-lite
official

Kratom alkaloids, August to November 2026: three new Schedule I listings, a pending 7-OH threshold, a court ruling in Massachusetts, and the 9-ODM shelf

by ch3ch3 · 1d ago · 0 comments

From August to November 2026 three opioids related to the kratom alkaloid 7-OH became federal Schedule I, a looser 7-OH threshold was proposed but has not become law, states adopted or rewrote their own lists, a Massachusetts court left that state's kratom ban in place, and shops filled a new shelf under names such as "9-ODM" and "MIT-9".

Federal

MGM-15, MGM-16 and mitragynine pseudoindoxyl are Schedule I. DEA's temporary order of August 26 placed all three in Schedule I⁠[1], until August 26, 2028⁠[1]. Our post: MGM-15, MGM-16 and mitragynine pseudoindoxyl are Schedule I; legal pages for MGM-15 and mitragynine pseudoindoxyl.

7-OH: a notice, still not an order. On October 14 DEA said it intends to place 7-OH and pseudoindoxyl in Schedule I at more than 1 mg per gram for solids or 1 mg per millilitre for liquids⁠[2], or when mitragynine divided by those alkaloids is less than 100⁠[2]. The order cannot publish until 30 days after the notice⁠[2]. DEA says it is withdrawing its July 7-OH notice⁠[2]. Until a new order publishes, pseudoindoxyl stays Schedule I with no threshold⁠[2]. Neither HHS nor DEA has found below-threshold amounts safe⁠[2]. As of November 21, the Federal Register shows no 7-OH order, no withdrawal of the July notice and no new MGM-15/MGM-16 order (our check of DEA documents published since October 14). Our post: DEA proposes a new Schedule I threshold; 7-OH legal status.

States and cities

Florida. The Attorney General's first emergency rule, 2ER26-1, listed 9-hydroxycorynantheidine, which it also called 9-O-demethylmitragynine and 8-OH⁠[3]. That is 9-ODM. The second rule, 2ER26-2, took effect August 18⁠[4] and superseded the first⁠[4]. Its summary lists 7-acetoxymitragynine, MGM-15, MGM-16 and 7-OH above a threshold⁠[5], and 9-ODM is not among them. See 9-ODM legal status.

New Jersey. Since September 25 the three federal compounds are illegal to possess and sell in New Jersey⁠[6], because a drug the federal government schedules is scheduled there automatically unless the state objects⁠[6]. Our post: New Jersey adopts the DEA order.

Massachusetts. On November 16 a Superior Court judge refused to block the state's kratom restrictions, according to the Governor's statement the next day⁠[7]. The Department of Public Health order took effect August 28 and lasts up to one year⁠[7]. We have not read the court's decision itself.

Already covered on this site: Louisiana and Missouri put the three in Schedule I. California reported its enforcement totals, and Georgia's attorney general asked stores to pull kratom. City and county rules came in Hillsborough County, Philadelphia and Irvine (overview: Cities and counties move on 7-OH). San Francisco reported its first fatal MGM-15 overdose, and New Jersey Poison Control warned about 7-OH withdrawal. Every state: the legal tracker.

The new shelf: names, not contents

After the August order, kratom shops opened categories sold as "9-ODM", "9ODM", "MIT-9" or "C9", alongside tablets named "13-OH", "15-OH", "MIT-OH", "M9" and "prop blend". These are pack names, not evidence of what is inside. When we read them against the certificates the sellers link, the names often did not match the contents. Only one 9-ODM tablet's certificate measured 9-ODM. Two products sold as MIT-9 measured mitragynine or were not tested for 9-ODM, and one shop's 9-ODM listings linked no certificate at all. "13-OH" turned out to be a plant extract the lab could not identify against a standard, and a "15-OH" tablet's certificate measures mitragynine. The evidence, with archived listings and certificates: 13-OH, 15-OH, MIT-OH, M9: product names that read like molecules, MIT-9, 9ODM, C9: what the 9-ODM tablets say on the pack, and what their certificates measured, and the 9-ODM substance page.

9-ODM (9-hydroxycorynantheidine) is a kratom alkaloid and one of mitragynine's major metabolites in rats (Chiang et al., 2024), with high affinity for the mu-opioid receptor in laboratory studies (Matsumoto et al., 2006). No federal document names it, and we found no published human safety data. Whatever the label says, a product that holds mitragynine, 9-ODM or 7-OH carries the known risks of opioid-receptor agonists (a class inference, not product data): dependence, tolerance and withdrawal, and dangerous sedation and slowed breathing when combined with alcohol, benzodiazepines or other opioids.

References

  1. Schedules of Controlled Substances: Temporary Placement of Mitragynine Pseudoindoxyl, MGM-15, and MGM-16 in Schedule I — Federal Register
  2. Schedules of Controlled Substances: Temporary Placement of 7- Hydroxymitragynine and Mitragynine Pseudoindoxyl Above a Specified Threshold in Schedule I — Federal Register
  3. Notice of Emergency Rule 2ER26-1, Department of Legal Affairs (Florida Administrative Register Vol. 52/122) — Florida Department of Legal Affairs, in the Florida Administrative Register
  4. Rule 2ER26-2, final adopted version in the Florida Administrative Code (file and effective dates) — Florida Department of State, Florida Administrative Code
  5. Notice of Emergency Rule 2ER26-2, Department of Legal Affairs (Florida Administrative Register Vol. 52/162) — Florida Department of Legal Affairs, in the Florida Administrative Register
  6. AG Davenport, Division of Consumer Affairs Issue Public Alert: Three Types of Synthetic Kratom To Be Listed as Controlled Dangerous Substances in New Jersey — New Jersey Office of the Attorney General and Division of Consumer Affairs
  7. Governor Healey Statement on Court Decision Allowing Kratom Restrictions to Remain in Effect — Office of Governor Maura Healey (with the Massachusetts Department of Public Health), on mass.gov
0

Comments

Sign in to join the conversation.

No comments yet.

Tell us something